期刊文献+

凋亡调节蛋白Fas和Caspase-3在乳腺癌中的表达及意义 被引量:3

Expression and significance of apoptosis regulatory proteins Fas and Caspase-3 in breast cancer
下载PDF
导出
摘要 目的观察人乳腺癌组织中凋亡调节蛋白Fas和Caspase-3的表达,探讨Fas和Caspase-3与乳腺癌发生、发展的关系。方法收集手术切除的人乳腺癌组织和癌旁相对正常乳腺组织(距癌组织5 cm以上),用免疫组织化学方法对23例乳腺癌标本进行检测。结果在相对正常乳腺组织和乳腺癌组织中Fas蛋白的阳性表达率分别为86.9%和47.3%;乳腺癌组织中Fas的阳性表达率明显低于相对正常乳腺组织。在相对正常乳腺组织和乳腺癌组织中Caspase-3的阳性表达率分别为82.6%和43.5%;乳腺癌组织中Caspase-3的阳性表达率明显低于相对正常乳腺组织。乳腺癌组织中caspase-3与Fas的表达率均与淋巴结转移无关。相关性分析表明,乳腺癌癌中的表达caspase-3与Fas表达呈正相关。结论乳腺癌组织中Fas和Caspase-3表达下调,使肿瘤抗凋亡机制过度激活,可能在乳腺癌的发生和发展过程中起重要作用。 Objective To investigate the expression of Fas and Caspase-3 in breast cancer tissue and explore development relations of Fas and Caspase-3 and breast cancer occurrence. Methods The human operation breast cancer tissues and relatively normal breast tissues were collected from surgical operation and the samples of 23 patients with breast cancer were analyzed by immunocytochemistry and computer imaging techniques. Results The results showed that in breast cancer tissue, the positive expressions of Fas was 47.3% and was significantly lower than that of normal breast tissues (86.9%), and there was a significant difference between them (P〈0.05). In breast cancer tissue, the positive expressions of Caspase-3 was 43.5% and was significantly lower than that of normal breast tissues (82.6%), and there was a significant difference between them (P〈0.05). Caspase-3 and Fas expression rates were associated with lymph node metastasis. There was a positive correlation between the expression of Fas and caspase-3 in breast cancer. Conclusion The reduced express of Fas and Caspase-3 caused Anti apoptotic mechanism of excessive activation of tumor and it may plays an important role in breast cancer occurrence and development.
出处 《解剖学研究》 CAS 2013年第2期93-96,共4页 Anatomy Research
基金 广东省大学生创新实验项目基金(1057310045)
关键词 乳腺癌 FAS CASPASE-3 免疫组织化学 Breast cancer Fas Caspase-3 Immunocytochemistry
  • 相关文献

参考文献9

  • 1Amalinei C, Cianga C, Balan R, et al. Immunohisto-chemical analysis of steroid receptors, proliferation markers, apoptosis related molecules, and gelatinases in non-neoplastic and neoplastic endometrium. Ann Anat, 2011,193(1) :43-55.
  • 2何洁华,梁小曼,候景辉,黄亦莉,吴秋良,肖永波.乳腺导管内乳头状瘤及其癌变组织CD44v6蛋白表达的研究[J].癌症,2002,21(6):615-618. 被引量:18
  • 3Roy S, Bayly CI, Gareau Y, et al. Maintenance of caspase-3 proenzyme dormancy by an intrinsic/safety catah O regulatory tripept ide. Proc Natql Acad Sci USA, 2001,98 ( 11 ) : 6132-6137.
  • 4Huang WW, Ko SW, Tsai HY, Cantharidin induces G2/ M phase arrest and apoptosis in human colorectal cancer colo 205 ceils through inhibition of CDK1 activity and caspase-dependent signaling pathways. Int J Oncol, 2011, 38(4) : 1067-1073.
  • 5Harwood FG, Kasibhatla S, Petak I, et al. Regulation of FasL by NF-kappaB and AP-1 in Fas-dependent thymineless death of human colon car cinoma cells . J Biol Chem, 2000,275 (14) : 10023-10027.
  • 6Hassan M, Feyen O, Grinstein E. Fas-induced apoptosis of renal cell carcinoma is mediated by apoptosis signal-regulating kinase 1 viamitochondrial damage-dependent caspase-8 activation. Cell Oncol, 2009,31 (6) : 437-456.
  • 7Das H, Koizumi T, Sugimoto T, et al. Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR. Br J Cancer, 2000,82 (10) : 1682-1688.
  • 8Pordzik S, Petrovici K, Schmid C, et al. Expression and prognostic value of FAS receptor/FAS ligand and TrailR1/ TrailR2 in acute myeloid leukemia. Hematology, 2011,16 (6) :341-350.
  • 9李艳萍,王琳,贾琴,张玉英,吴燕名.Fas/FasL和Bcl-2在人乳腺癌组织中的表达及其与浸润淋巴细胞的关系[J].解剖学研究,2009,31(5):338-341. 被引量:4

二级参考文献15

  • 1Shi-Yong Li, Bo Yu, Ping An, Jia-Chen Wei, Fu-Yi Zuo and Hui-Yun Cai Beijing, China Department of General Surgery, Beijing Military Commend General Hospital, Beijing 100700, China.Influence of FasL gene expression on hepatic metastasis of colorectal carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2004,3(2):226-229. 被引量:14
  • 2童强,刘科,王国斌.FasL Expression in Colorectal Carcinoma and Its Significance in Immune Escape of Cancer[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2006,26(1):79-81. 被引量:3
  • 3[1]Naot D,Sionov RV,Ish Shalom D. CD44:structure,function,and assiociation with the malignant process [J]. Adv Cancer Res,1997,71:241- 319.
  • 4[2]Herrera Gayol A,Jothy S. Adhesion protein in the biology of breast cancer: contribution of CD44 [J]. Exp Mol Pathol,1999,66(2):149- 156.
  • 5[3]Kaufmann M,Heider KH,Sinn HP,et al. CD44 variant exon epitpes in primary breast cancer and length of survival [J]. Lancet,1995,345(8950):615- 619.
  • 6[4]Dall P,Herider KH,Sinn HP,et al. Comparison of immunohistochemistry and RT PCR for detection of CD44v expression,a new prognostic factor in human breast cancer [J]. Int J Cancer,1995,60(4):471- 477.
  • 7[5]Rosen PP,Oberman HA. Tumors of the Mammary Gland [M]. Washington D.C: Armed Forces Institute of Pathology,1992,72- 76.
  • 8[6]Papotti M,Eusebi V,Gugliotta P,et al. Immunohistochemical analysis of benign and malignant papillary lesions of the breast [J]. Am J Surg Pathol,1983,7(5):451- 461.
  • 9[7]Mackay CR,Terpe HJ,Stauder R,et al. Expression and modulation of CD44 variant isoforms in humans [J]. J Cell Biol,1994,124(1- 2):71- 82.
  • 10[8]Mastsumura Y,Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation [J]. Lancet,1992,340(8827):1053- 1058.

共引文献20

同被引文献42

  • 1燕平,艾淑颖,李志玖,何清华.希罗达联合多西紫杉醇治疗晚期乳腺癌40例临床观察[J].实用癌症杂志,2014,29(3):327-329. 被引量:7
  • 2宋彦,宋永胜.凋亡相关蛋白Fas及caspase-3在膀胱移行细胞癌中表达及临床意义[J].肿瘤,2007,27(6):465-468. 被引量:5
  • 3Combs GF Jr. Current evidence and research needs to support a health Claim for selenium and cancer.preven- tion. J Nutr, 2005,135(2) :343-347.
  • 4Brinkman M, Buntinx F, Muls E, et al. Use of selenium in chemoprevention of bladder cancer. Lancet Oncol, 2006,7 (9) : 766-774.
  • 5Behne D, Kyriakopoulos A. Mammalian selenium-con- taining proteins. Annu Rev Nutr, 2001,21:453-473.
  • 6Stammer K, Edassery SL, Barua A, et al. Selenium-Bind- ing Protein 1 expression in ovaries and ovarian tumors of in the laying hen, a spontaneous model of human ovarian cancer. Gynecol Oncol, 2008,109( 1 ) : 115-121.
  • 7Zhang P, Zhang C, Wang X, et aL. The expression of selenium-binding protein 1 is decreased in uterine leiomyoma. Diagn Pathol, 2010,9 (5) : 80.
  • 8Chen G, Wang H, Miller CT, et al. Reduced selenium-binding protein 1 expression is associated with poor out- come in lung adenocarcinomas. J Pathol, 2004,202 (3) : 321-329.
  • 9Silvers AL, Lin L, Bass A J, et al. Decreased selenium- binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and af- fects chemosensitivity. Clin Cancer Res, 2010,16(7): 2009-2021.
  • 10Zhang J, Zhan N, Dong WG. Altered expression of sele- nium-binding protein 1 in gastric carcinoma and precursor lesions. Med Oncol, 2011,28 (4) : 951-957.

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部